Disease Overview：Nephrolithiasis（NL）
Renal calculi, or kidney stones, are solid crystalline aggregates formed from urinary solutes—most commonly calcium oxalate, calcium phosphate, uric acid, or struvite—within the renal collecting system. They range in size from microscopic niduses to staghorn calculi occupying entire calyceal systems. Symptoms vary widely: asymptomatic stones may be incidentally detected on imaging, while larger or obstructing stones often present with acute flank pain (renal colic), hematuria, nausea, and sometimes urinary tract infection or obstruction-induced renal impairment. Diagnosis relies on non-contrast CT urography—the gold standard for sensitivity and specificity—alongside ultrasound and metabolic evaluation including 24-hour urine chemistry and serum electrolytes to guide prevention. Management is stratified by stone size, location, composition, and patient factors: conservative measures (hydration, analgesia, medical expulsive therapy) suffice for small distal ureteral stones; minimally invasive interventions—including extracorporeal shock wave lithotripsy (ESWL), ureteroscopy with laser lithotripsy (URS), and percutaneous nephrolithotomy (PCNL)—are employed for larger or complex stones.
China offers distinct advantages for international patients seeking renal stone management. The country’s nephrology and urology centers—many affiliated with top-tier academic hospitals—boast internationally trained specialists with extensive experience in high-volume stone disease centers. Advanced platforms such as ultra-mini PCNL, flexible digital ureteroscopes, and real-time intraoperative imaging enhance precision and reduce complication rates. Clinical outcomes align with global benchmarks: over 95% stone-free rates for URS and PCNL in experienced centers, supported by robust post-procedural metabolic follow-up programs. Crucially, treatment costs in China are typically 40–60% lower than in the US, UK, or Germany—even accounting for travel—without compromising evidence-based protocols or accreditation standards (e.g., JCI-certified facilities). As a dedicated medical tourism agency, we streamline the entire journey for international patients: verifying physician credentials, coordinating appointments at vetted hospitals, providing itemized, transparent pricing in advance, arranging interpreters and logistics, and offering continuous clinical and administrative support—from pre-travel consultation through post-discharge follow-up.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Renal Calculi (Nephrology Department)
Non-Surgical / Conservative Management
*Indicated for stones ≤6 mm, no obstruction/infection, stable renal function.*
- •Medical Expulsive Therapy (MET): Tamsulosin 0.4 mg/day × 4–6 weeks
- •Hydration & Analgesia: IV fluids (if dehydrated), NSAIDs (diclofenac IV/oral)
- Diclofenac injection (75 mg): $4–$9 per dose
- •Diagnostic Workup (mandatory baseline):
- Renal ultrasound + Doppler: $45–$75 - Serum creatinine, eGFR, uric acid, calcium, phosphorus: $38–$62 - Urinalysis + culture: $12–$22
Surgical / Interventional Procedures
*Indicated for stones >6 mm, obstruction, infection, or failed MET.*
- •Extracorporeal Shock Wave Lithotripsy (ESWL)
- Procedure fee: $420–$780 - Pre-op: CT KUB + urine culture + ECG + coagulation panel ($210–$340)
- •Ureteroscopy (URS) with Laser Lithotripsy
- Procedure (including stent placement): $1,250–$2,100 - Pre-op: CT KUB + cystoscopy prep + anesthesia assessment ($290–$460)
- •Percutaneous Nephrolithotomy (PCNL)
- Procedure (single-stage, including nephrostomy tube): $2,800–$4,600 - Pre-op: CT urogram + pulmonary function test + cardiac echo if indicated ($410–$680)
Special/Complex Condition Management
- •Staghorn Calculus (Infection-related): Requires PCNL + 14-day IV antibiotics (e.g., ceftriaxone + amikacin) → $3,900–$6,200 total
- •Cystinuria or Primary Hyperoxaluria: Lifelong thiol drugs (tiopronin) + high-volume hydration → annual drug cost $1,100–$1,900, plus quarterly stone analysis ($85) and 24-hr urine metabolic panel ($145)
- •Renal Impairment (eGFR <45 mL/min): Avoid NSAIDs; prioritize URS/PCNL over ESWL; dialysis coordination adds $220–$360 per session if needed pre-op
Quick Selection Guide
- •<40 years, stone ≤5 mm, no comorbidities: Start with MET + hydration ($150–$280 total)
- •60+ years, diabetes/hypertension, 8-mm obstructing stone: URS preferred over ESWL (lower re-treatment rate) → $1,600–$2,600
- •Budget-constrained (<$1,000): ESWL + rigorous MET ($650–$1,200) — avoid if stone >1.5 cm
- •Recurrent stones + metabolic syndrome: Mandatory 24-hr urine + genetic/metabolic workup ($230–$330) before long-term prevention
- •Staghorn or sepsis: Immediate PCNL + IV antibiotics ($4,200–$6,800) — delay risks renal loss
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Nephrolithiasis Medical Vacation Packages
Curated transparent all-inclusive packages combining Nephrolithiasis treatment with China top medical destinations:
